Results 41 to 50 of about 546,164 (358)

Advanced Glycation End Products’ Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

open access: yesGenetics Research, 2023
Background. Advanced glycation end products’ receptor (AGER) is a multiligand receptor that interacts with a wide range of ligands. Previous studies have shown that abnormal AGER expression is closely related to immune infiltration and tumorigenesis ...
Jun Yang   +10 more
doaj   +1 more source

A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. [PDF]

open access: yes, 2012
Metastatic non-small cell lung cancer (NSCLC) carries a dismal prognosis. Clinical evidence suggests the existence of an intermediate, or oligometastatic, state when metastases are limited in number and/or location.
Niibe, Yuzuru   +4 more
core   +3 more sources

Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy

open access: yesBMC Urology, 2017
Background Our aim was to assess the heterogeneity of high-risk (HR) prostate cancer managed with high-dose external beam radiotherapy (EBRT) with androgen deprivation therapy (ADT).
Daniel N. Cagney   +9 more
doaj   +1 more source

WeWhoCurie: An Initiative to Advocate for Those Underrepresented in Radiation Oncology

open access: yesAdvances in Radiation Oncology, 2023
Purpose: An initiative to advocate for those underrepresented in radiation oncology. Methods and Materials: Inspired by the success of the #ILookLikeAnEngineer and #ILookLikeASurgeon campaigns, this initiative aimed to break down stereotypes in ...
Joy Ogunmuyiwa, MD, MPH   +9 more
doaj   +1 more source

ACR Accreditation for Utah Valley Hospital’s Radiation Oncology Center

open access: yes, 2019
Becoming an accredited clinic through the American College of Radiology (ACR) and their Radiation Oncology Practice Accreditation (ROPA) program will provide third-party evaluation of patient care to ensure the best treatment possible for patients.
Manigold, Remy
core   +1 more source

Interobserver Reliability in Describing Radiographic Lung Changes After Stereotactic Body Radiation Therapy [PDF]

open access: yes, 2018
Purpose Radiographic lung changes after stereotactic body radiation therapy (SBRT) vary widely between patients. Standardized descriptions of acute (≤6 months after treatment) and late (\u3e6 months after treatment) benign lung changes have been proposed
Hugo, Geoffrey D.   +6 more
core   +3 more sources

Prospects for Radiopharmaceuticals as Effective and Safe Therapeutics in Oncology and Challenges of Tumor Resistance to Radiotherapy

open access: yesDose-Response, 2021
The rapid advances in nuclear medicine have resulted in significant advantages for the field of oncology. The focus is on the application of radiopharmaceuticals as therapeuticals.
Ekaterina Nikolova   +3 more
doaj   +1 more source

The landscape of digital resources in radiation oncology

open access: yesTechnical Innovations & Patient Support in Radiation Oncology, 2022
In recent years, the number of educational medical resources accessible to residents and practicing radiation oncologists online has grown exponentially to include discussion boards, wikis, videos, podcasts, journal clubs, online communities, and ...
Matthew M. Culbert   +2 more
doaj   +1 more source

Case Report: The impact of the ESTRO-IAEA Best Practice in Radiation Oncology train the RTT trainers project for Serbian RTTs

open access: yesTechnical Innovations & Patient Support in Radiation Oncology, 2018
The European Society of Radiotherapy and Oncology (ESTRO)/International Atomic Energy Agency (IAEA) Best Practice in Radiation Oncology project to train the RTT trainers (TTT) has had a very positive impact on improving the continuous education of ...
Ilija Čurić
doaj   +1 more source

Training in Radiation and Clinical Oncology in Europe

open access: yesJournal of Medical Education and Curricular Development, 2023
The European population is strongly affected by cancer. Radiotherapy is roughly used in 50% of cancer patients in European countries. The increased cancer burden demands a new generation of radiation/clinical oncologist (RO/CO) that, besides a strong ...
Pedro C Lara   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy